Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

131 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A randomised, double-blind, placebo-controlled, multicentre study of the safety and efficacy of BIOBYPASS (AdGVVEGF121.10NH) gene therapy in patients with refractory advanced coronary artery disease: the NOVA trial.
Kastrup J, Jørgensen E, Fuchs S, Nikol S, Bøtker HE, Gyöngyösi M, Glogar D, Kornowski R. Kastrup J, et al. Among authors: nikol s. EuroIntervention. 2011 Feb;6(7):813-8. doi: 10.4244/EIJV6I7A140. EuroIntervention. 2011. PMID: 21252014 Clinical Trial.
Gene therapy in vascular disease.
Sedighiani F, Nikol S. Sedighiani F, et al. Among authors: nikol s. Surgeon. 2011 Dec;9(6):326-35. doi: 10.1016/j.surge.2011.05.003. Epub 2011 Jul 5. Surgeon. 2011. PMID: 22041646 Review.
Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia.
Nikol S, Baumgartner I, Van Belle E, Diehm C, Visoná A, Capogrossi MC, Ferreira-Maldent N, Gallino A, Wyatt MG, Wijesinghe LD, Fusari M, Stephan D, Emmerich J, Pompilio G, Vermassen F, Pham E, Grek V, Coleman M, Meyer F; TALISMAN 201 investigators. Nikol S, et al. Mol Ther. 2008 May;16(5):972-8. doi: 10.1038/mt.2008.33. Epub 2008 Apr 1. Mol Ther. 2008. PMID: 18388929 Free article. Clinical Trial.
Therapeutic Angiogenesis With Intramuscular NV1FGF Improves Amputation-free Survival in Patients With Critical Limb Ischemia.
Nikol S, Baumgartner I, Van Belle E, Diehm C, Visoná A, Capogrossi MC, Ferreira-Maldent N, Gallino A, Graham Wyatt M, Dinesh Wijesinghe L, Fusari M, Stephan D, Emmerich J, Pompilio G, Vermassen F, Pham E, Grek V, Coleman M, Meyer F. Nikol S, et al. Mol Ther. 2008 May;16(5):972-978. doi: 10.1038/mt.2008.33. Epub 2016 Dec 8. Mol Ther. 2008. PMID: 28178491
Prioritization of treatments for lower extremity peripheral artery disease in low- and middle-income countries.
Fowkes FG, Forster RB, Levin CE, Naidoo NG, Roy A, Shu C, Spertus J, Fang K, Bechara-Zamudio L, Catalano M, Visonà A, Nikol S, Fletcher JP, Jaff MR, Hiatt WR, Norgren L. Fowkes FG, et al. Among authors: nikol s. Int Angiol. 2017 Jun;36(3):203-215. doi: 10.23736/S0392-9590.16.03716-0. Epub 2016 Jul 7. Int Angiol. 2017. PMID: 27386953 Free article. Review.
5 Conservative treatment for PAD - Risk factor management.
Frank U, Nikol S, Belch J. Frank U, et al. Among authors: nikol s. Vasa. 2019 Dec;48(Suppl 102):1-12. doi: 10.1024/0301-1526/a000835. Epub 2019 Oct 3. Vasa. 2019. PMID: 31578114 No abstract available.
Self-Expanding Versus Balloon-Expandable Stents for Iliac Artery Occlusive Disease: The Randomized ICE Trial.
Krankenberg H, Zeller T, Ingwersen M, Schmalstieg J, Gissler HM, Nikol S, Baumgartner I, Diehm N, Nickling E, Müller-Hülsbeck S, Schmiedel R, Torsello G, Hochholzer W, Stelzner C, Brechtel K, Ito W, Kickuth R, Blessing E, Thieme M, Nakonieczny J, Nolte T, Gareis R, Boden H, Sixt S. Krankenberg H, et al. Among authors: nikol s. JACC Cardiovasc Interv. 2017 Aug 28;10(16):1694-1704. doi: 10.1016/j.jcin.2017.05.015. JACC Cardiovasc Interv. 2017. PMID: 28838480 Free article. Clinical Trial.
131 results